Cabergoline therapy for Macroprolactinoma during pregnancy: A case report

BACKGROUND: We assessed the safety of Cabergoline therapy during pregnancy in a lady with hyperprolactinemia intolerant to Bromocriptine. CASE PRESENTATION: We report the case of a 31 year old lady who presented to us with uncontrolled hyperprolactinemia. A pituitary Macroadenoma was demonstrated by...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahzad, Hira, Sheikh, Aisha, Sheikh, Lumaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575245/
https://www.ncbi.nlm.nih.gov/pubmed/23110890
http://dx.doi.org/10.1186/1756-0500-5-606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575245/
https://www.ncbi.nlm.nih.gov/pubmed/23110890
http://dx.doi.org/10.1186/1756-0500-5-606

Ejemplares similares